SolveItNCERT · CBSE Boards

CBSE 2025 · Region 1 · Set 1 · Q21 · 2 marks

Student to attempt either option-(A) or (B) :
A patient with ADA deficiency requires periodic infusion of genetically engineered lymphocytes. Explain why such periodic infusion is required and also suggest a permanent cure for such ADA deficiency.

Biotechnology and its ApplicationsBiotechnological Applications in MedicineUnderstandvery_short_answerhard

More from Biotechnology and its Applications

CBSE Class 12 Biology past-paper question from the 2025board exam, with the answer as CBSE’s own marking scheme gives it. Where our answers come from.